De Novo
DEN220090: EasySep™ Human Bone Marrow CD138 Positive Selection Kit (100-0748)
FDA De Novo · stemcell technologies canada inc. · decided Nov 6, 2023
Key facts
| De Novo number | DEN220090 |
|---|---|
| Device name | EasySep™ Human Bone Marrow CD138 Positive Selection Kit (100-0748) |
| Applicant | stemcell technologies canada inc. |
| Product code | QYO |
| Date received | Dec 12, 2022 |
| Decision date | Nov 6, 2023 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Medical Genetics |
| FEI number | 3004450619 |
At a glance
- None Later 510(k)s citing this De Novo
- 1–9 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: